Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-03Clinical Trial Update: A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung Cancer [Phase 3]
Phase 3 study of a pemetrexed/cisplatin/gefitinib combination in Asian non-smoking patients with non-small cell lung cancer completed with r…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Study of Participants With Advanced Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial update for participants with advanced non-small cell lung cancer; status completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial at the University of Chicago comparing cetuximab alone versus pemetrexed/cetuximab therapy for non-small cell lung cancer wa…
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: A Multi-Centered Trial Evaluating the Role of Vitamin D Metabolism in Non-Small Cell Lung Cancer
A multi-center clinical trial investigating Vitamin D metabolism in non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer [NA]
This National Cancer Institute-sponsored clinical trial update reports the completion of a study evaluating Erlotinib in patients with stage…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-03-27Clinical Trial Update: Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating radiation therapy with paclitaxel and carboplatin in stage III non-small cell lung cancer has completed with resu…
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC [Phase 3]
A Phase III trial evaluating RRM1 and ERCC1 directed customized chemotherapy for non-small cell lung cancer has completed and posted results…
-
CLINICAL_TRIALS trial_result · 2014-03-24Clinical Trial Update: Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
A completed Phase 1/2 study evaluating motesanib with or without carboplatin/paclitaxel or panitumumab in advanced non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: A Non-interventional Survey on the EGFR (Epidermal Growth Factor Receptor) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma Histology
AstraZeneca-conducted, non-interventional study completed, surveying EGFR mutation status in Chinese patients with completely resected non-s…
-
CLINICAL_TRIALS trial_result · 2014-03-17Clinical Trial Update: Celecoxib and Radiation Therapy in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Completed phase 1/2 trial evaluating the combination of celecoxib with radiation therapy in locally advanced non-small cell lung cancer; res…
-
CLINICAL_TRIALS trial_result · 2014-03-17Clinical Trial Update: Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer [NA]
This clinical trial update notes the termination of a study evaluating multimodal hypoxia imaging combined with intensity-modulated radiothe…
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: A Dose Ascending Study of Gemcitabine Elaidate (CO-101) in Combination With Cisplatin [Phase 1]
Phase 1 dose-escalation study of gemcitabine elaidate (CO-101) with cisplatin for solid tumors, including non-small cell lung cancer, has be…
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer [Phase 2]
Phase II trial assessing carboplatin plus gemcitabine in patients with Stage IIIB non-small cell lung cancer and Stage IV non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating palifermin for reducing dysphagia in locally advanced non-small cell lung cancer has completed, with results posted…
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating bevacizumab with paclitaxel and carboplatin plus chest radiation for locally advanced non-small cell lung cancer; t…
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer [Phase 1]
This is a completed Phase 1 study evaluating fondaparinux (Arixtra) in combination with chemotherapy for patients with advanced non-small ce…
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC) [Phase 2]
Phase 2 trial evaluating cetuximab with conformal thoracic radiotherapy in patients with inoperable or unresectable locally advanced non-sma…
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
A Phase 3 clinical trial evaluating Tarceva (erlotinib) in patients with advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-03Clinical Trial Update: Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating a biweekly schedule of docetaxel and cisplatin in unresectable non-small cell lung cancer. The study is completed a…
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel, carboplatin, and radiation therapy in patients undergoing surgery for stage III non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® in NSCLC Subjects [Phase 1]
Phase 1 study to determine the maximum tolerated dose and evaluate pharmacokinetics, safety, tolerability, and preliminary efficacy of Hocen…
-
CLINICAL_TRIALS trial_result · 2014-02-25Clinical Trial Update: Afatinib Plus Nimotuzumb for NSCLC [Phase 1, Phase 2]
Clinical trial update on a Phase 1/2 study evaluating the combination of afatinib and nimotuzumab for non-small cell lung cancer, with curre…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer Patient [Phase 2]
Phase 2 clinical trial investigating a theranostic tool used during erlotinib treatment for patients with metastatic or recurrent non-small …
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Intermittent and Maintenance of Erlotinib in Combination With Pemetrexed/Carboplatin in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation [Phase 2]
This document reports a Phase 2 trial update evaluating intermittent and maintenance erlotinib plus pemetrexed/carboplatin in advanced EGFR-…
-
CLINICAL_TRIALS trial_result · 2014-02-17Clinical Trial Update: Dose Escalation Of Icotinib In Previously Treated Patients With Routine Dose [Phase 4]
Phase 4 dose-escalation study evaluating icotinib in previously treated non-small cell lung cancer patients.